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The passing of Jean Berger on 22 May 2011 marks the end of an era. He was the renal pathologist who first described IgA nephropathy, and whose seminal 
work coincided with the burgeoning of renal 
biopsy as a ground-breaking investigative tool 
in kidney disease.
Jean Berger was born on 17 September 1930. 
He became Interne des Hôpitaux de Paris (the 
equivalent of residency) in 1954. Working in the 
Department of Nephrology headed by Professor 
Jean Hamburger at the Necker-Enfants Malades 
Hospital in Paris, he became interested in pathol-
ogy. He qualified as a specialist in medicine in 
1960, writing a thesis entitled, “Contribution of 
the renal biopsy to the pathological knowledge 
of the kidney diseases.”
Renal biopsy had initially emerged in the early 
1950s as an innovative tool for the understand-
ing and classification of glomerular diseases 
on the basis of morphology defined by light 
microsc opy. Then, during the late 1950s, electron 
microscopy was first applied to kidney biopsy 
material. Berger, working with Pierre Galle, 
an electron microscopist, described “fibrinoid 
intercapillary deposits” in patients with chronic 
glomerulonephritis, a first step toward his future 
description of IgA nephropathy. They also made 
the first description of dense deposits within the 
glomerular basal membranes.
At the same time, Berger had trained with 
the pathologist Deborah Doniach in London in 
order to apply fluorescent techniques to the kid-
ney. Fluorescently labeled antibodies were first 
used to detect proteins in the early 1950s, but 
until the mid-1960s very few laboratories offered 
this technique, and the antisera were often of 
poor specificity. By 1963, antibodies were avail-
able commercially, but laboratories studying 
immunofluorescence in kidney biopsies mostly 
used only anti-IgG reagents, as IgG was thought 
to be the predominant immunoglobulin class 
involved in the immunopathogenesis of nephri-
tis. Berger was helped by Professor Bernard 
Antoine, an immunologist working at Necker-
Enfants Malades Hospital, who developed the 
methodology for immunofluorescence. They 
tested commercial sera and labeled them with 
fluorescein; anti-IgA specificity was confirmed 
with an anti-IgA serum produced by Professor 
Maxime Seligmann (who had made the first 
description of anti-DNA antibodies).
Berger had developed a fruitful partnership 
with two other pathologists. Nicole Hinglais was 
in charge of light and electron microscopy in the 
pathology department of Hamburger’s nephrol-
ogy clinic (she would later discover the charac-
teristic ultrastructural lesions of the glomerular 
basement membrane in Alport syndrome). The 
immunofluorescence technique was performed 
in the laboratory of Dr. Halina Yaneva. Liliane 
Striker (née Morel-Maroger) has published a 
memoir from her own experience as a research 
fellow in the 1960s, in which she describes the 
excitement of those days when Berger identified 
the new nephropathy that was to bear his name.
In 1967, at a session of the Actualités Néphro-
logiques de l’Hôpital Necker, Berger presented 
a panorama of renal lesions based on their 
immuno fluorescence pattern. Among these find-
ings, he had identified glomerular IgA deposits in 
a few patients with chronic glomerulonephritis or 
Henoch–Schönlein purpura. An oral report to the 
Société de Néphrologie in Paris in the winter of 
1968 was followed by the publication in French of 
a summary less than one page long.1 This report, 
now cited time and again all over the world, was 
entitled “Les dépôts intercapillaires d’IgA-IgG.” It 
concerned 25 patients presenting with recurrent 
hematuria and with focal and segmental lesions 
by light microscopy, in whom the IgA reagent 
‘outshone’ the IgG reagent strongly. As Profes-
sor Stewart Cameron has reminded us, biopsies 
of children with recurrent hematuria and focal 
glomerulonephritis had already been studied by 
immunofluorescence, but only with the use of 
antisera against IgG.
Berger extended his observations the following 
year,2 describing a nephropathy characterized by 
the presence of mesangial IgA–IgG deposits in 55 
patients with a range of light microscopy appear-
ances, most commonly focal glomerulonephritis. 
All patients had moderate proteinuria and per-
sistent microscopic hematuria, and 22 “had one 
or several bouts of gross hematuria which usually 
occurred during a sore throat.” He remarked, “The 
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course of the disease appeared to be remarkably 
slow,” but in one patient renal transplantation 
was needed, and biopsy of the transplant showed 
recurrent IgA deposits. IgA deposits were also 
identified in lupus and Henoch–Schönlein 
purpura nephritis.
There was at first some reluctance to give 
credence to Berger’s observations by acknowl-
edging IgA nephropathy as a distinct clinico-
pathological entity. For a short time it was 
thought that the disease was confined to France, 
but the finding of predominant mesangial IgA 
in patients with mesangial or focal glomeru-
lonephritis was soon realized to be common 
worldwide. Berger and his colleagues at the 
Necker-Enfants Malades Hospital went on to 
show that mesangial IgA deposits recurred fre-
quently in transplanted kidneys,3 noting that 
graft function was usually not impaired, and 
therefore that “the high incidence of recurrence 
was not a contraindication to transplantation.” 
Studying alcoholic liver disease, they showed 
the high frequency of glomerular IgA deposits 
previously noted by others in a few cases.
Jean Berger made further epidemiological 
observations. He reported that in France IgA 
nephropathy accounted for 20–25% of cases of 
primary glomerulonephritis and was an impor-
tant cause of terminal renal disease, accounting at 
that time for 15% of cases of glomerulonephritis 
requiring renal transplantation. He was interested 
by the high frequency of IgA nephropathy in 
many parts of the world and was especially puz-
zled by the high frequency of IgA mesangiopathic 
glomerulonephritis in the Zuni Indians.
Berger’s later work was devoted to under-
standing the pathogenesis of the disease. He 
reported that inadvertently grafted kidney with 
IgA deposits reversed after transplantation,4 
concluding from this case as well as from recur-
rence of IgA deposits after transplantation that 
circulating rather than local kidney abnormal-
ities were responsible for the disease. Working 
in collaboration with Necker hospital immuno-
nephrologists, he characterized abnormalities 
in deposited IgA eluted from biopsies, an 
important step in the identification of a major 
pathogenic factor of the disease.
Different names have been used for IgA nephro-
pathy over the past 40 years. In 1972 the term ‘Berg-
er’s disease’ was first proposed for IgA nephropathy 
by a French group, although subsequently this term 
was sometimes restricted to those patients who had 
recurrent episodes of visible hematuria.
It might be tempting to belittle Berger’s obser-
vations with the apparent wisdom of hindsight. 
After all, he merely applied a new technique and 
got an interesting answer, the sort of thing that 
in modern scientific vernacular we might term a 
‘fishing expedition.’ But Berger’s original 1968–
1969 reports were more than just a novel obser-
vation; they introduced a new level of descriptive 
classification into the study of glomerulonephri-
tis, and highlighted the confusion of the time 
about the classification of glomerular diseases, 
which even now awaits full resolution. Should 
glomerulonephritis be classified by morphology 
on light microscopy, by the pattern of immune 
deposits defined by immunofluorescence or 
electron microscopy, or by clinical presenta-
tion, or by etiology? The presence of IgA depos-
its remains to date the only means to diagnose 
IgA nephropathy, now recognized to be the most 
common glomerulonephritis.
Jean Berger had a high opinion of his work, but 
was a vigorous critic of others’. He was a relentless 
reader of the kidney literature, endowed with an 
excellent memory, and had a perpetually enquir-
ing mind. One of his last sentences published 
stated that “Despite this effort, the pathogen-
esis of IgA nephropathy remains mysterious. It 
is clear that there is something wrong with IgA 
in these patients, but the precise defect has not 
been uncovered, and no treatment has proved to 
be effective.” These words define the challenges 
that remain ahead for nephrologists worldwide.
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